Adverum Biotechnologies Inc (ADVM)
6.94
+0.33
(+4.99%)
USD |
NASDAQ |
Sep 27, 16:00
6.96
+0.02
(+0.29%)
After-Hours: 20:00
Adverum Biotechnologies 30-Day Average Daily Volume: 172803.6 for Sept. 27, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
Date | Value |
---|---|
September 27, 2024 | 172803.6 |
September 26, 2024 | 173182.7 |
September 25, 2024 | 175154.9 |
September 24, 2024 | 175989.4 |
September 23, 2024 | 170816.0 |
September 20, 2024 | 168944.2 |
September 19, 2024 | 170047.9 |
September 18, 2024 | 167576.2 |
September 17, 2024 | 160306.0 |
September 16, 2024 | 167745.5 |
September 13, 2024 | 169236.4 |
September 12, 2024 | 174608.2 |
September 11, 2024 | 178332.5 |
September 10, 2024 | 183843.5 |
September 09, 2024 | 188257.5 |
September 06, 2024 | 194133.8 |
September 05, 2024 | 202139.9 |
September 04, 2024 | 212363.1 |
September 03, 2024 | 217459.3 |
August 30, 2024 | 227818.7 |
August 29, 2024 | 243531.7 |
August 28, 2024 | 277947.1 |
August 27, 2024 | 342557.0 |
August 26, 2024 | 351170.9 |
August 23, 2024 | 356088.2 |
Date | Value |
---|---|
August 22, 2024 | 359804.6 |
August 21, 2024 | 368400.6 |
August 20, 2024 | 370033.0 |
August 19, 2024 | 368987.8 |
August 16, 2024 | 367009.3 |
August 15, 2024 | 367015.6 |
August 14, 2024 | 366602.5 |
August 13, 2024 | 378452.5 |
August 12, 2024 | 386727.2 |
August 09, 2024 | 481618.3 |
August 08, 2024 | 490318.7 |
August 07, 2024 | 490018.2 |
August 06, 2024 | 498077.1 |
August 05, 2024 | 497801.1 |
August 02, 2024 | 489308.4 |
August 01, 2024 | 488276.3 |
July 31, 2024 | 490539.1 |
July 30, 2024 | 486650.8 |
July 29, 2024 | 482841.4 |
July 26, 2024 | 481969.0 |
July 25, 2024 | 480285.2 |
July 24, 2024 | 474744.2 |
July 23, 2024 | 463382.6 |
July 22, 2024 | 457045.5 |
July 19, 2024 | 446350.9 |
30-Day Average Daily Volume Range, Past 5 Years
126977.2
Minimum
Feb 02 2024
4.611M
Maximum
Jun 09 2021
1.058M
Average
888151.2
Median
30-Day Average Daily Volume Benchmarks
EyePoint Pharmaceuticals Inc | 569702.5 |
Cassava Sciences Inc | 1.737M |
Regenxbio Inc | 472742.8 |
Editas Medicine Inc | 1.856M |
Apellis Pharmaceuticals Inc | 1.511M |